药物发现
天然产物
小分子
纳米技术
计算生物学
组合化学
药品
计算机科学
化学
材料科学
生物
立体化学
生物化学
药理学
作者
Raphael Meneghello,Joane K. Rustiguel,Evandro Ares de Araújo,Rafael de Felício,Adriana Fernandes,Éverton L. F. Ferreira,Juliana R. Gubiani,Agnes A. S. Takeda,Amanda Aparecida de Araújo,Clóvis A. Silva,Ariane F. Bertonha,Raquel P. Morais Urano,Daniel Maragno Trindade,Thiago M. Cunha,Alisson C. Cardoso,Roberto G. S. Berlinck,Andrey Fabricio Ziem Nascimento,Daniela Barretto Barbosa Trivella
标识
DOI:10.1107/s2053230x25001542
摘要
Nature is a rich and largely untapped reservoir of small molecules, the latter historically being the main source of new drugs. Three-dimensional structures of proteins in complex with small-molecule ligands represent key information to progress drug-discovery projects, in particular in the hit-to-lead phase. High-throughput crystallography has been of extensive use in recent years, especially to obtain crystallographic complexes of synthetic ligands and fragments. However, the process of discovering novel bioactive natural products has experienced limitations that have long prevented large drug-discovery programs using this outstanding source of molecules. Recent technologies have contributed to the re-emergence of natural products in modern drug discovery. We present the use of high-throughput protein crystallography to directly capture bioactive natural products from unpurified biota chemical samples using protein crystals. These routines, which are currently in use at the Brazilian Centre for Research in Energy and Materials (CNPEM), are introduced with a description of crystal preparation, automated data collection and processing at the MANACÁ beamline (Sirius, LNLS, CNPEM), along with case examples of bioactive natural product capture using protein crystals. The usefulness of this pipeline, which accelerates the discovery and structural elucidation of both known and previously unknown bioactive natural products, paves the way for the development of innovative therapeutic agents, thus contributing to the new era of natural product-based drug discovery.
科研通智能强力驱动
Strongly Powered by AbleSci AI